Follow
CARMELO GURNARI
CARMELO GURNARI
Cleveland Clinic/University of Rome Tor Vergata
Verified email at universitadipavia.it
Title
Cited by
Cited by
Year
The combination of bortezomib with chemotherapy to treat relapsed/refractory acute lymphoblastic leukaemia of childhood
A Bertaina, L Vinti, L Strocchio, S Gaspari, R Caruso, M Algeri, V Coletti, ...
British journal of haematology 176 (4), 629-636, 2017
812017
Germ line DDX41 mutations define a unique subtype of myeloid neoplasms
H Makishima, R Saiki, Y Nannya, S Korotev, C Gurnari, J Takeda, ...
Blood 141 (5), 534-549, 2023
652023
Vacuolization of hematopoietic precursors: an enigma with multiple etiologies
C Gurnari, S Pagliuca, L Durkin, L Terkawi, H Awada, S Kongkiatkamon, ...
Blood, The Journal of the American Society of Hematology 137 (26), 3685-3689, 2021
602021
Germline DDX41 mutations cause ineffective hematopoiesis and myelodysplasia
TM Chlon, E Stepanchick, CE Hershberger, NJ Daniels, KM Hueneman, ...
Cell Stem Cell 28 (11), 1966-1981. e6, 2021
542021
Machine learning integrates genomic signatures for subclassification beyond primary and secondary acute myeloid leukemia
H Awada, A Durmaz, C Gurnari, A Kishtagari, M Meggendorfer, CM Kerr, ...
Blood, The Journal of the American Society of Hematology 138 (19), 1885-1895, 2021
412021
Clinical and molecular determinants of clonal evolution in aplastic anemia and paroxysmal nocturnal hemoglobinuria
C Gurnari, S Pagliuca, PH Prata, JE Galimard, LFB Catto, L Larcher, ...
Journal of Clinical Oncology 41 (1), 132, 2023
362023
The emerging role of measurable residual disease detection in AML in morphologic remission
F Buccisano, L Maurillo, GJ Schuurhuis, MI Del Principe, A Di Veroli, ...
Seminars in hematology 56 (2), 125-130, 2019
362019
How I manage acquired pure red cell aplasia in adults
C Gurnari, JP Maciejewski
Blood, The Journal of the American Society of Hematology 137 (15), 2001-2009, 2021
352021
The similarity of class II HLA genotypes defines patterns of autoreactivity in idiopathic bone marrow failure disorders
S Pagliuca, C Gurnari, H Awada, A Kishtagari, S Kongkiatkamon, ...
Blood, The Journal of the American Society of Hematology 138 (26), 2781-2798, 2021
292021
The role of forkhead box proteins in acute myeloid leukemia
C Gurnari, G Falconi, E De Bellis, MT Voso, E Fabiani
Cancers 11 (6), 865, 2019
292019
Single-cell characterization of leukemic and non-leukemic immune repertoires in CD8+ T-cell large granular lymphocytic leukemia
J Huuhtanen, D Bhattacharya, T Lönnberg, M Kankainen, C Kerr, ...
Nature Communications 13 (1), 1981, 2022
282022
Essential thrombocythemia and acquired von willebrand syndrome: the shadowlands between thrombosis and bleeding
H Awada, MT Voso, P Guglielmelli, C Gurnari
Cancers 12 (7), 1746, 2020
282020
When poisons cure: the case of arsenic in acute promyelocytic leukemia
C Gurnari, E De Bellis, M Divona, T Ottone, S Lavorgna, MT Voso
Chemotherapy 64 (5-6), 238-247, 2020
272020
Congenital Rhabdomyosarcoma: a different clinical presentation in two cases
I Russo, V Di Paolo, C Gurnari, A Mastronuzzi, F Del Bufalo, PL Di Paolo, ...
Bmc Pediatrics 18, 1-5, 2018
272018
Demethylation and up-regulation of an oncogene after hypomethylating therapy
YC Liu, J Kwon, E Fabiani, Z Xiao, YV Liu, MY Follo, J Liu, H Huang, ...
New England Journal of Medicine 386 (21), 1998-2010, 2022
252022
Have we reached a molecular era in myelodysplastic syndromes?
MT Voso, C Gurnari
Hematology 2021 (1), 418-427, 2021
252021
UBA1 screening in sweet syndrome with hematological neoplasms reveals a novel association between VEXAS and chronic myelomonocytic leukemia
C Gurnari, P Mannion, I Pandit, S Pagliuca, MT Voso, JP Maciejewski, ...
Hemasphere 6 (10), e775, 2022
242022
Individual HLA heterogeneity and its implications for cellular immune evasion in cancer and beyond
S Pagliuca, C Gurnari, MT Rubio, V Visconte, TL Lenz
Frontiers in Immunology 13, 944872, 2022
232022
Applications and efficiency of flow cytometry for leukemia diagnostics
MI Del Principe, E De Bellis, C Gurnari, E Buzzati, A Savi, MAI Consalvo, ...
Expert Review of Molecular Diagnostics 19 (12), 1089-1097, 2019
232019
Myeloid lncRNA LOUP mediates opposing regulatory effects of RUNX1 and RUNX1-ETO in t(8;21) AML
BQ Trinh, S Ummarino, Y Zhang, AK Ebralidze, MA Bassal, TM Nguyen, ...
Blood, The Journal of the American Society of Hematology 138 (15), 1331-1344, 2021
222021
The system can't perform the operation now. Try again later.
Articles 1–20